202 related articles for article (PubMed ID: 21558844)
21. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
Ameri A; Wilhelm A; Simmet T
Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
[TBL] [Abstract][Full Text] [Related]
22. Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant.
Paquette JJ; Wang HY; Bakshi K; Olmstead MC
Behav Pharmacol; 2007 Dec; 18(8):767-76. PubMed ID: 17989514
[TBL] [Abstract][Full Text] [Related]
23. WIN-55,212-2 chronically implanted into the CA3 region of the dorsal hippocampus impairs learning: a novel method for studying chronic, brain-area-specific effects of cannabinoids.
Barna I; Soproni K; Arszovszki A; Csabai K; Haller J
Behav Pharmacol; 2007 Sep; 18(5-6):515-20. PubMed ID: 17762520
[TBL] [Abstract][Full Text] [Related]
24. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.
Sheinin A; Talani G; Davis MI; Lovinger DM
J Neurophysiol; 2008 Aug; 100(2):1041-52. PubMed ID: 18497350
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
Terranova JP; Michaud JC; Le Fur G; Soubrié P
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):576-9. PubMed ID: 8751088
[TBL] [Abstract][Full Text] [Related]
26. CB1 cannabinoid receptor agonists increase intracranial self-stimulation thresholds in the rat.
Vlachou S; Nomikos GG; Panagis G
Psychopharmacology (Berl); 2005 May; 179(2):498-508. PubMed ID: 15821959
[TBL] [Abstract][Full Text] [Related]
27. Biphasic effects of cannabinoids on acetylcholine release in the hippocampus: site and mechanism of action.
Tzavara ET; Wade M; Nomikos GG
J Neurosci; 2003 Oct; 23(28):9374-84. PubMed ID: 14561865
[TBL] [Abstract][Full Text] [Related]
28. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
Liu Q; Bhat M; Bowen WD; Cheng J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.
Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872
[TBL] [Abstract][Full Text] [Related]
30. Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices.
Ameri A; Simmet T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):265-72. PubMed ID: 10731038
[TBL] [Abstract][Full Text] [Related]
31. Recruitment of hippocampal neurons to encode behavioral events in the rat: alterations in cognitive demand and cannabinoid exposure.
Goonawardena AV; Robinson L; Riedel G; Hampson RE
Hippocampus; 2010 Sep; 20(9):1083-94. PubMed ID: 19771586
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid receptor activation in CA1 pyramidal cells in adult rat hippocampus.
Kirby MT; Hampson RE; Deadwyler SA
Brain Res; 2000 Apr; 863(1-2):120-31. PubMed ID: 10773200
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat.
Goonawardena AV; Robinson L; Hampson RE; Riedel G
Learn Mem; 2010 Oct; 17(10):502-11. PubMed ID: 20876271
[TBL] [Abstract][Full Text] [Related]
34. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
Fattore L; Spano M; Melis V; Fadda P; Fratta W
Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
[TBL] [Abstract][Full Text] [Related]
35. Intrinsic effects of AM4113, a putative neutral CB1 receptor selective antagonist, on open-field behaviors in rats.
Järbe TU; LeMay BJ; Olszewska T; Vemuri VK; Wood JT; Makriyannis A
Pharmacol Biochem Behav; 2008 Nov; 91(1):84-90. PubMed ID: 18640150
[TBL] [Abstract][Full Text] [Related]
36. Diuretic effects of cannabinoids.
Paronis CA; Thakur GA; Bajaj S; Nikas SP; Vemuri VK; Makriyannis A; Bergman J
J Pharmacol Exp Ther; 2013 Jan; 344(1):8-14. PubMed ID: 23019138
[TBL] [Abstract][Full Text] [Related]
37. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
[TBL] [Abstract][Full Text] [Related]
38. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses.
Kim J; Alger BE
Nat Neurosci; 2010 May; 13(5):592-600. PubMed ID: 20348918
[TBL] [Abstract][Full Text] [Related]
39. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats.
Fattore L; Cossu G; Martellotta CM; Fratta W
Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718
[TBL] [Abstract][Full Text] [Related]
40. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus.
Hoffman AF; Macgill AM; Smith D; Oz M; Lupica CR
Eur J Neurosci; 2005 Nov; 22(9):2387-91. PubMed ID: 16262678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
